Efficacy and safety of levodopa in secondary dystonia due to neurological Wilson disease (LIDWID)
Efficacy and safety of levodopa in secondary dystonia due to neurological Wilson disease (LIDWID)
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Abstract
BACKGROUND:
Dystonia is the most prevalent movement disorder in neurologic Wilson disease (NWD). While levodopa has demonstrated efficacy in certain forms of primary dystonia, its effectiveness in NWD has not been evaluated. This study aimed to evaluate the efficacy and safety of levodopa compared to placebo in patients with dystonia...
Alternative Titles
Full title
Efficacy and safety of levodopa in secondary dystonia due to neurological Wilson disease (LIDWID)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_340b6b107e224565b107ca3380d2742c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_340b6b107e224565b107ca3380d2742c
Other Identifiers
ISSN
2590-3446
E-ISSN
2590-3454
DOI
10.4103/aomd.aomd_95_24
